Loading...
NPI 1447477252 · Hato Rey, PR · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Ammvr Group, Inc is a clinical medical laboratory provider located in Hato Rey, Puerto Rico. This profile covers 17 Medicare and 90 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Ammvr Group, Inc |
| Address | 724 Ave Ponce De Leon |
| City | Hato Rey |
| State | PR |
| ZIP | 00919 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | April 20, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $6.7M |
| Medicare | $8K |
AMMVR GROUP, INC is effectively a Medicaid-focused clinical laboratory: lifetime Medicaid revenue is $6.7M versus only $8K in Medicare, indicating the provider’s payer mix is overwhelmingly Medicaid. The NPI was enumerated on 2007-04-20 (~19 years ago), confirming a long-tenured operation concentrated on state Medicaid business rather than Medicare volume.
The provider’s Medicaid code mix is dominated by HIV and STI diagnostics and immune monitoring: 87536 (HIV–1 viral load), 87591 (Neisseria gonorrhoeae NAAT), and 87491 (Chlamydia trachomatis NAAT) together account for the precomputed top-3 share of 43.7% of Medicaid revenue. High volumes for CD4 testing (86361) and related immunoassays further reinforce that the lab’s core service line is large-scale infectious disease and HIV program testing rather than routine outpatient chemistry for Medicare patients.
Medicaid billing is highly concentrated in a handful of codes: the single code 87536 generates $1.8M (30.1% of Medicaid revenue) and ranks #1 of 42 providers in-state (100th percentile; extreme outlier, far above typical state volume for this code). The prominence of 86361 (13.6K claims, $365.9K; ranks #1 of 24 in-state, 100th percentile) and other top-ranked immunology assays shows the provider is a primary in-state destination for specialized HIV monitoring services.
By contrast, Medicare activity is a small fraction of the business and exhibits modest national standing: total Medicare revenue is $8K and the precomputed top-3 Medicare codes account for 32.4% of that Medicare revenue. Leading Medicare codes—82306, 80061, and 87635—produce limited Medicare receipts (e.g., 82306 $957, 80061 $845) and show middle-to-low national percentiles (for example 82306 ranks #7686 of 12453 nationally, 37th percentile), indicating the provider is a modest national participant on Medicare panels.
The provider’s state competitive standing on many Medicaid codes is dominant: multiple codes hold top in-state ranks (for example, 87536 and 86361 both rank #1 of their peer sets at the 100th percentile, and other assays such as 83690, 86704, 86708, 82150, and 86706 also rank #1 in-state). In addition, numerous other Medicaid codes are reported at very high state percentiles (96–99th), which collectively signal that AMMVR is a major, high-throughput laboratory for public-health-related testing in Puerto Rico.
Operational throughput is reflected in very large Medicaid claim counts on core assays—87536 shows 22K claims, 80061 29.7K claims, and 85025 34.5K claims—supporting the interpretation of a centralized, high-volume testing operation. These claim volumes, paired with many codes ranked at or near the top in-state, suggest established specimen collection and processing capacity scaled to serve population-level HIV/STI screening and surveillance.
Revenue concentration creates business sensitivity: with 43.7% of Medicaid revenue coming from the top three Medicaid codes and a single code (87536) representing 30.1% of Medicaid revenue, payer policy, reimbursement changes, or programmatic shifts affecting HIV viral load or NAAT reimbursement could materially impact overall revenue. Given Medicare revenue of only $8K and a top-3 Medicare concentration of 32.4%, the lab has limited Medicare diversification to offset Medicaid-specific shifts.
While the Medicaid footprint is dominant and concentrated in specialized infectious-disease panels, the Medicare profile shows routine clinical chemistry and preventive screening tests (e.g., lipid panel 80061, vitamin D 82306, CBC 85025) at modest volumes and national percentiles. This dual picture indicates AMMVR operates primarily as a public-health and HIV/STI diagnostic center at scale in-state, with a secondary, low-volume presence in standard Medicare laboratory services.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
17 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 30 | $30 | $960 |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 70 | $10 | $850 |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 20 | $50 | $800 |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 100 | $10 | $780 |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 50 | $20 | $740 |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 70 | $10 | $720 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 30 | $20 | $600 |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 20 | $30 | $540 |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 40 | $10 | $430 |
| 81000 | The lab analyst inserts a dip stick into a freshly collected urine specimen, removes the dip stick, and shakes off the excess urine. Alternatively, the analyst may place drops of the urine specimen… | 70 | $1 | $260 |
Showing 1–10 of 17
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
90 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87536 | A lab tests a patient’s specimen to measure the amount of HIV–1 present. This may be referred to as viral load. | 21,950 | $80 | $1.8M |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 11,740 | $40 | $422.7K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 11,790 | $40 | $412.6K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 29,720 | $10 | $386.3K |
| 86361 | The lab analyst performs an absolute CD4 cell count test to measure the number of CD4 cells in each micro liter of a patient specimen, typically in a blood specimen. The provider may order this test… | 13,550 | $30 | $365.9K |
| 86360 | The lab analyst performs a test to measure the number of CD4 and CD8 cells, typically in a blood specimen, including a calculation of the ratio between the two. The provider may order a CD4, CD8 and… | 7,620 | $50 | $343.1K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 5,820 | $50 | $279.1K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 30,260 | $10 | $272.3K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 34,500 | $10 | $241.5K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 16,060 | $10 | $224.8K |
Showing 1–10 of 90
How this provider's Medicaid billing volume and revenue compare to other Puerto Rico providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Puerto Rico median
90 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 87536 | A lab tests a patient’s specimen to measure the amount of HIV–1 present. This may be referred to as viral load. | 1 | 40 | 250 | $80 | $140.8K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 71 | 650 | 1,260 | $40 | $93.7K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 24 | 770 | 2,520 | $20 | $65.5K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 28 | 590 | 1,440 | $20 | $65.4K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 14 | 370 | 370 | $50 | $63.3K |
| 86360 | The lab analyst performs a test to measure the number of CD4 and CD8 cells, typically in a blood specimen, including a calculation of the ratio between the two. The provider may order a CD4, CD8 and… | 2 | 30 | 320 | $40 | $58.5K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 12 | 810 | 2,350 | $10 | $52.7K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 8 | 290 | 170 | $30 | $43.8K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 8 | 310 | 190 | $30 | $43.1K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 11 | 790 | 2,360 | $10 | $41.9K |
Showing 1–10 of 90
Other providers in the same ZIP code as Ammvr Group, Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Sherry Santiago-castro | PR | Neurology with Special Qualifications in Child Neurology Physician | $0 | $1.5M |
| Hope Med Psc | PR | Internal Medicine Physician | $0 | $865.9K |
| Ricardo Colacioppo Saavedra | PR | Cardiovascular Disease Physician | $36.3K | $37.3K |
| Alexis Canino Rodriguez | PR | Cardiovascular Disease Physician | $13.4K | $26.8K |
| Mario Haddad | PR | Specialist | $25.5K | $0 |
| Veronica Meza-venencia | PR | Nephrology Physician | $15.4K | $7.4K |
| Jovanna Bertran-lopez | PR | Infectious Disease Physician | $18.7K | $0 |
| Jorge Suarez Colon | PR | General Practice Physician | $18.1K | $0 |
| Maria Martinez Colon | PR | Dermatology Physician | $16.8K | $0 |
| Marigloria Ortiz Gonzalez | PR | Physical Therapist | $12.5K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.